Browse by Series:

Choosing Frontline and Second-line Therapy for NSCLC

Mark A. Socinski, MD
Published: Wednesday, May 17, 2017



Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
Slider Left
Slider Right


Mark A. Socinski, MD, Florida Hospital Cancer Institute, discusses how to decide first-line therapy, second-line therapy, and beyond for patients with non–small cell lung cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x